Is Zolgensma approved in India?

It is important to note that Zolgensma isn’t marketed in India, and has to be imported from the US if prescribed by a medical practitioner.

Is Spinraza available in India?

As per the company, Evrysdi is the first and only approved treatment available in the country against this fatal genetic disorder. Until now, SMA in India was curable only with the two most expensive and imported gene therapy injections — Spinraza and Zolgensma — from Biogen-Ionis and Novartis Gene Therapies.

What is the cost of medicine for spinal muscular atrophy?

The Novartis manufactured Zolgensma gene therapy to treat spinal muscular atrophy (SMA) is the most expensive medicine globally; it costs 2.1 million US dollars, about Rs 15.24 crore in Indian currency.

How many SMA cases are there in India?

SMA affects approximately one in 10,000 live births globally and one in 7,744 live births in India. Without treatment, babies with the most severe form of SMA, Type 1, cannot sit unsupported.

Is SMA common in India?

Spinal Muscular Atrophy (SMA) is a common cause of death for children in India leading to about one in 7,744 children dying. If not diagnosed or left untreated, the child does not survive beyond two years of age.

Which is the costliest injection in the world?

Doctors recommended Zolgensma, said to be world’s most expensive drug costing Rs 17 crore, saying it could help stop the disease from damaging Vedika’s muscles. The injection was procured for Rs 16 crore. “Around Rs 16 crore was raised through multiple platforms.

What is spinal muscular atrophy treatment cost in India?

Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottle.

Which is the costliest drug in India?

The world’s most expensive medicine Zolgensma was administered to a kid from Hyderabad, who was suffering from a rare disease, known as Spinal Muscular Atrophy (SMA).

How many children suffer from SMA in India?

Spinal Muscular Atrophy (SMA) is a common cause of death for children in India leading to about one in 7,744 children dying.

Why is SMA common in India?

Spinal muscular atrophy (SMA) represents the second most common fatal autosomal recessive disorder after cystic fibrosis. Due to the high carrier frequency, the burden of this genetic disorder is very heavy in developing countries like India.

How is Spinal muscular atrophy (SMA) treated?

There is no complete cure for SMA. Treatment consists of managing the symptoms and preventing complications. In December 2016 the U.S. Food and Drug Administration approved nusinersen (Spinraza™) as the first drug approved to treat children and adults with SMA. The drug is administered by injection into the fluid surrounding the spinal cord.

Is there a cure for SMA?

Many of the symptoms of SMA relate to secondary complications of muscle weakness. GIOSTAR has developed the techniques to differentiate the Stem cells into the high purity motor neuron progenitor cells. These cells have ability to regenerate the new and healthy neurons after transplantation and may cure the disease.

How does SMA affect the muscular system?

Normally, signals from the neurons to the muscles cause muscles to contract. In SMA, motor neurons are lost, and muscles can’t function. What are the genetic causes of SMA? The most common form of SMA (types 1-4) is caused by a defect (mutation) in the SMN1 gene on chromosome 5.

What does SMMA stand for?

World’s Largest Stem Cell Hospital funded by the government of India. Stem Cell Treatment of Spinal Muscular Atrophy (SMA) Spinal Muscular Atrophy (SMA) is a neuromuscular disease characterized by degeneration of motor neurons, resulting in progressive muscular atrophy (wasting away) and weakness.